Institut de Recherche Clinique du Benin

The Institut de Recherche Clinique du Bénin (IRCB) is a prominent clinical research organization and scientific institution based in Abomey-Calavi, Benin. Established in 2015 and led by Professor Achille Massougbodji, the institute is dedicated to advancing medical knowledge and health innovation through rigorous clinical trials and epidemiological research. IRCB focuses primarily on infectious and metabolic diseases endemic to sub-Saharan Africa, with significant expertise in malaria prevention, vaccine immunogenicity, and neglected tropical diseases. The institute operates state-of-the-art laboratories for molecular biology and immunology and maintains extensive collaborations with international partners such as the IRD and various global health consortia. By conducting high-impact studies like the PfVIMT vaccine trial and the DeWorm3 project, IRCB plays a vital role in shaping public health policies and improving care quality in the region.